RxDoctor Payments Data

Jennifer Holley, PA

Physician Assistant · Smithfield, NCNPI 1477032498

Payments from drug & device makers

$7,653in general payments, 2019–2025

Across 436 payments — averaging $17.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$989
  • Lilly USA, LLC$703
  • Pfizer$497
  • Merck$461
  • AstraZeneca$304
  • plus $3K from 39 others

What the payments were for

  • Food & beverage$7,653100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,653 in reported general payments places this provider in the 95th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$63,291
Medicare patients
188
Services billed
1,292

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide49$43,640
JanuviaSitagliptin Phosphate20$29,596
JardianceEmpagliflozin30$27,461
EliquisApixaban30$26,341
TrulicityDulaglutide24$26,107
Trelegy ElliptaFluticasone/Umeclidin/Vilanter29$22,274
RybelsusSemaglutide17$19,434
XareltoRivaroxaban14$9,953
LinzessLinaclotide11$7,953
Synjardy XrEmpagliflozin/Metformin Hcl11$6,764
Atorvastatin Calcium150$3,013
SynthroidLevothyroxine Sodium26$1,981
Fluticasone-SalmeterolFluticasone Propion/Salmeterol22$1,760
Pantoprazole Sodium77$1,292
Tramadol Hcl57$1,059

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$989$63,07366 claims
Boehringer IngelheimJardiance, Synjardy Xr$228$34,22541 claims
MerckJanuvia$461$29,59620 claims
PfizerEliquis$497$26,34130 claims
Lilly USA, LLCTrulicity$703$26,10724 claims
GSKTrelegy Ellipta$249$22,27429 claims
Johnson & JohnsonXarelto$58$9,95314 claims
AbbVieLinzess, Synthroid$1,360$9,93437 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Smithfield

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →